Medisur's first twelve health self-tests were initially distributed to the general public through pharmacies. The Covid-19 crisis then led the company to temporarily refocus on the production of SARS-CoV-2 detection devices, with several million tests sold in France and abroad, before expanding its product range to include health and safety prevention in the workplace, its current positioning.